Last updated on August 2020

A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Seizure Disorders | Partial Seizures With or Without Secondary Generalization | Seizure Disorders (Pediatric) | Epilepsy
  • Age: Between 16 - 80 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Subjects (male or female) from 16 to 80 years of age at Visit 1, both inclusive
  • Female subjects with childbearing potential are eligible if they use a medically accepted contraceptive method
  • Subjects having at least 8 partial seizures (according to the 1981 ILAE classification) during the 8-Week Baseline Period with at least 2 partial seizures during each 4-week interval of the Baseline Period
  • Subjects having at least 2 partial seizures whether or not secondary generalization per month during the 3 months preceding Visit 1
  • Subjects uncontrolled while treated by 1 or 2 permitted concomitant antiepileptic drug [AED](s). Vagal Nerve Stimulation (VNS) is allowed and will be counted as a concomitant AED

Exclusion Criteria:

  • Subject has history or presence of status epilepticus during the year preceding Visit 1 or during Baseline
  • Subject is currently treated with levetiracetam
  • Subject has taken levetiracetam within 90 days prior to Visit 1

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.